Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors
Clinical trial NCT00100347 · TERMINATED
Trial details
- NCT number
- NCT00100347
- Sponsor
- PRAECIS Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.